TEM insider trading
NasdaqGS HealthcareTempus AI, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Tempus AI, Inc.
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaboration agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology, as well as strategic collaboration with Personalis, Inc. and Whitehawk Therapeutics, Inc. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Company website: www.tempus.com
TEM insider activity at a glance
FilingIQ has scored 558 insider transactions for TEM since Jun 13, 2024. The most recent filing in our index is dated May 4, 2026.
Across the full history, 0 open-market purchases
and 439 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TEM insider trades is 60.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TEM Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding TEM
Frequently asked
- How many insider trades does FilingIQ track for TEM?
- FilingIQ tracks 558 Form 4 insider transactions for TEM (Tempus AI, Inc.), covering filings from Jun 13, 2024 onwards. 37 of those were filed in the last 90 days.
- Are TEM insiders net buyers or net sellers?
- Across the full Form 4 history for TEM, 0 transactions (0%) were open-market purchases and 439 (79%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TEM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is TEM in?
- Tempus AI, Inc. (TEM) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $10.38B.
Methodology & sources
Every TEM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.